Effect of Dexmedetomidine as an Adjuvant to Bupivacaine in Ultrasound-Guided Erector Spinae Plane Block for Cesarean Section - A Randomized Controlled Trial.

In 30 seconds

This randomized controlled trial evaluated the effectiveness of dexmedetomidine as an adjuvant to bupivacaine in erector spinae plane blocks for 50 patients undergoing cesarean sections. The study found that the addition of dexmedetomidine significantly reduced total analgesic consumption in the first 24 hours postoperatively, with a mean difference of 1.2 doses compared to bupivacaine alone (3.3 vs 2.1, p=0.001).

Key findings

• Total analgesic doses were significantly lower in the dexmedetomidine group (2.1 vs 3.3, p=0.001).
• The time to first request for analgesia was longer in the dexmedetomidine group (12.6 h vs 8.3 h, p=0.001).
• The duration of block was significantly extended with dexmedetomidine (16.47 h vs 10.95 h, p=0.001).
• Bradycardia incidence was higher in the dexmedetomidine group (p=0.01).

Why it matters

The findings suggest that incorporating dexmedetomidine into erector spinae plane blocks can enhance postoperative pain management in cesarean sections, potentially leading to reduced analgesic requirements and improved patient comfort.